Serotonin transporter gene as predictor of recovery after surgery

ISRCTN ISRCTN40219584
DOI https://doi.org/10.1186/ISRCTN40219584
Secondary identifying numbers 6719
Submission date
29/04/2010
Registration date
29/04/2010
Last edited
21/02/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Barry Wright
Scientific

31 Shipton Road
York
YO30 5RE
United Kingdom

Study information

Study designNon-randomised interventional screening trial
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeScreening
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleSerotonin transporter gene polymorphisms as a predictor of recovery after laporoscopic cholecystectomy: a non-randomised interventional screening trial
Study objectivesRecovery from surgery is highly variable. Having a better understanding of factors affecting this is useful in planning surgery, monitoring the effects of surgery and in conducting further research to improve recovery for future patients. Research has found that psychosocial factors, particularly attitudinal and mood factors, were strongly predictive of surgical outcomes, even after accounting for known clinical factors.

Work is underway to find biological markers for outcomes in major surgery, but there are currently no known biological markers identified for good or poor psychosocial recovery to date. However, the serotonin transporter gene polymorphism represents a possible marker. The promotor region of the serotonin transporter gene is present as homozygous (two short, ss, or two long, ll alleles) or heterozygous. Numerous studies have found that following a major life event, depression was more likely to occur in individuals carrying the short allele (ss, sl).

The aim of the present study is to investigate whether the serotonin transporter gene polymorphism is related to psychosocial recovery after a common operation, laparoscopic cholecystectomy. To do this, we will assess the polymorphic status of 250 individuals due to have laparoscopic cholecystectomy and give them a range of self report questionnaires to fill in before the surgery and 6 weeks after.
Ethics approval(s)York Research Ethics Committee, 29/08/2007, ref: 07/H1311/69
Health condition(s) or problem(s) studiedTopic: Mental Health Research Network; Subtopic: Service Delivery; Disease: Not Applicable
Intervention1. Buccal swab - taken before the operation an analysed for the serotonin gene length polymorphism only
2. Questionnaires - filled in by participants before the operation and 6 weeks after: 2.1. 36-item short form health survey (SF-36)
2.2. Hospital Anxiety and Depression Scale (HAD)
2.3. Beck Depression Inventory (BDI)
2.4. Chalder Fatigue Scale
2.5. Visual Analogue Pain Scale
2.6. Eysenck Personality Questionnaire (EPQ-R)
2.7. Unvalidated questionnaire on pre- and post-operative milestones (e.g. time back to work etc)

Follow up length: 12 months
Intervention typeProcedure/Surgery
Primary outcome measureChange in score on the Beck Depression Inventory (BDI), scored on a scale of 0 - 63, measured on day before operation and 6 weeks after.
Secondary outcome measures1. Change in scores on Health Anxiety and Depression (HAD) questionnaire, Chalder's Fatigue Scale, Eysenck Personality Questionnaire - Revised and 36-item short form health survey (SF-36), measured on day before operation and 6 weeks after
2. Visual Analogue Scale (VAS), measured day after operation and 6 weeks after
3. Unvalidated questionnaire to assess current health, measured before operation
4. Unvalidated questionnaire to assess common post-operative milestones, measured 6 weeks after operation
Overall study start date01/01/2008
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsPlanned Sample Size: 250; UK Sample Size: 250
Key inclusion criteria1. Patients undergoing elective laparoscopic cholecystectomy
2. Male and female, aged 18 - 65 years
Key exclusion criteriaPatients undergoing open laporoscopic cholecystectomy
Date of first enrolment01/01/2008
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

31 Shipton Road
York
YO30 5RE
United Kingdom

Sponsor information

York Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

Learning and Research Centre
Wigginton Road
York
YO31 8HE
England
United Kingdom

Website http://www.york.nhs.uk/
ROR logo "ROR" https://ror.org/027e4g787

Funders

Funder type

Charity

BUPA Foundation (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 06/09/2016 Yes No

Editorial Notes

21/02/2018: Publication reference added.
02/08/2016: No publications found, verifying study status with principal investigator.